Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare Tumors

Purpose. The prognosis of advanced soft tissue sarcoma is poor, only a few drugs showing some activity with response rates around 15– 25%. Consequently drug development seems mandatory to improve treatment outcome. Following previous favourable EORTC experience, the Italian Group on Rare Tumors star...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Santoro, Armando, Romanini, Antonella, Rosso, Alberto, Frustaci, Sergio, Comandone, Alessandro, Apice, Gaetano, De Toma, Domenico, Dogliotti, Luigi, Lionetto, Rita, Dani, Carla, Bruzzi, Paolo, Piolini, Marco, Bergnolo, Paola, Verusio, Claudio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 1999
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395431/
https://ncbi.nlm.nih.gov/pubmed/18521282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13577149977613
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller